LYRA · Lyra Therapeutics, Inc.
$0.25
+0.00 (+0.00%)
At close · Aug 13
Going-concern doubt
— flagged Mar 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern”View the 10-K filed Mar 31, 2026
Market Cap
$443,720
Shares
1.77M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-27 | Palasis Maria | Officer, Director | 1,895 | 2026-01-27 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Palasis Maria | Officer, Director | 1,702 | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2025-10-14 | Palasis Maria | Officer, Director | 537 | 2025-10-14 | Fidelity Brokerage Services LLC |
| 2025-07-10 | Palasis Maria | Officer, Director | 1,565 | 2025-07-10 | Fidelity Brokerage Services LLC |
| 2025-04-25 | Waksal Harlan | Officer, Director | 145,370 | 2025-04-25 | Fidelity Brokerage Services LLC |
| 2025-04-09 | Palasis Maria | Officer, Director | 39,567 | 2025-04-09 | Fidelity Brokerage Services LLC |
Showing 1–6 of 6 filings